TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Elexir Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
107,534
|
87,081
|
81,156 |
Financial expenses |
11
|
52
|
13 |
Earnings before taxes |
12,247
|
11,994
|
12,353 |
EBITDA |
12,380
|
12,175
|
12,687 |
Total assets |
45,371
|
34,987
|
30,450 |
Current assets |
41,840
|
34,261
|
29,750 |
Current liabilities |
13,111
|
9,611
|
8,081 |
Equity capital |
30,870
|
24,361
|
19,909 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
15
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
69.6%
|
65.4% |
Turnover per employee |
7,169
|
8,708
|
8,116 |
Profit as a percentage of turnover |
11.4%
|
13.8%
|
15.2% |
Return on assets (ROA) |
27.0%
|
34.4%
|
40.6% |
Current ratio |
319.1%
|
356.5%
|
368.1% |
Return on equity (ROE) |
39.7%
|
49.2%
|
62.0% |
Change turnover |
20,453
|
5,925
|
13,757 |
Change turnover % |
23%
|
7%
|
20% |
Chg. No. of employees |
5
|
0
|
3 |
Chg. No. of employees % |
50%
|
0%
|
43% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.